Abstract
A major advance over the last 40 years has been the improved outcome from common malignancies. This has been due, in part, to the availability and improved usage of effective cytotoxic chemotherapy and supportive care. However in some conditions, such as acute leukemia, the use of empirical antimicrobial therapy has been equally important. This chapter will briefly outline some of the important advances in the management of febrile neutropenia over the last 40 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bodey, G.P., Buckley, M., Sathe, Y.S., and Freireich, E.J. (1966). Quantitative relationships between circulating leukocytes and infection in patients with acute leukaemia. Ann. Intern. Med. 64, 328–340.
Haupt, R., Romanengo, M., Fears, T., Viscoli, C., and Castagnola, E. (2001). Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: A 12-year experience at a single Italian institution. Eur. J. Cancer. 37, 2413–2419.
Jack, D., Klein, N., and Turner, M. (2001). Mannose-binding lectin: Targeting the microbial world for complement attack and opsonophagocytosis. Immunol. Rev. 180, 86–99.
Neth, O., Jack, D., Johnson, M., Klein, N., and Turner, M. (2002). Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin (MBL) with MBL-associated serine protease following binding to Staphylococcus aureus. J. Immunol. 169, 4430–4436.
Neth, O., Hann, I., Turner, M.W., and Klein, N.J. (2001). Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 358, 614–618.
Peterslund, N.A., Koch, C., Jensenius, J.C., and Thiel, S. (2001). Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358, 637–638.
Schimpff, S., Satterlee, W., Young, V.M., and Serpick, A. (1971). Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N. Eng. J. Med. 284, 1061–1065.
Schimpff, S., Gaya, H., Klastersky, J., Tattersall, M.H., and Zinner, S.H. (1978). Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J. Infect. Dis. 137, 14–29.
Viscoli, C. and Castagnola, E. (1995). Factors predisposing cancer patients to infection. Cancer Treat. Res. 79, 1–30.
Viscoli, C. and Castagnola, E. (2002). Treatment of febrile neutropenia: What is new? Curr. Opin. Infect. Dis. 15, 377–382.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Science+Business Media New York
About this paper
Cite this paper
Neth, O., Klein, N. (2004). Febrile Neutropenia: Past, Present and Future. In: Pollard, A.J., McCracken, G.H., Finn, A. (eds) Hot Topics in Infection and Immunity in Children. Advances in Experimental Medicine and Biology, vol 549. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8993-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8993-2_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4751-4
Online ISBN: 978-1-4419-8993-2
eBook Packages: Springer Book Archive